Janney Montgomery Scott
TEVA icon

Janney Montgomery Scott’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$34.7M Sell
2,070,854
-8,427
-0.4% -$141K 0.09% 219
2025
Q1
$32M Buy
2,079,281
+588,295
+39% +$9.04M 0.09% 220
2024
Q4
$32.9M Buy
1,490,986
+90,661
+6% +$2M 0.09% 212
2024
Q3
$25.2M Buy
1,400,325
+17,545
+1% +$316K 0.07% 279
2024
Q2
$22.5M Buy
1,382,780
+10,303
+0.8% +$167K 0.07% 285
2024
Q1
$19.4M Buy
1,372,477
+164,614
+14% +$2.32M 0.06% 337
2023
Q4
$12.6M Buy
1,207,863
+389,136
+48% +$4.06M 0.04% 432
2023
Q3
$8.35M Buy
818,727
+6,407
+0.8% +$65.4K 0.03% 497
2023
Q2
$6.12M Sell
812,320
-23,804
-3% -$179K 0.02% 620
2023
Q1
$7.4M Sell
836,124
-6,440
-0.8% -$57K 0.03% 510
2022
Q4
$7.68M Sell
842,564
-49,038
-5% -$447K 0.03% 518
2022
Q3
$7.2M Sell
891,602
-1,288
-0.1% -$10.4K 0.03% 494
2022
Q2
$6.99M Buy
892,890
+26,013
+3% +$204K 0.03% 477
2022
Q1
$8.14M Buy
866,877
+37,565
+5% +$353K 0.03% 439
2021
Q4
$6.64M Buy
829,312
+38,212
+5% +$306K 0.03% 534
2021
Q3
$7.71M Buy
791,100
+31,162
+4% +$304K 0.03% 455
2021
Q2
$7.52M Buy
759,938
+15,640
+2% +$155K 0.03% 451
2021
Q1
$8.59M Buy
744,298
+274,909
+59% +$3.17M 0.04% 370
2020
Q4
$4.53M Buy
469,389
+168,651
+56% +$1.63M 0.02% 570
2020
Q3
$2.71M Buy
300,738
+23,413
+8% +$211K 0.02% 683
2020
Q2
$3.42M Buy
277,325
+225,951
+440% +$2.79M 0.02% 575
2020
Q1
$461K Buy
51,374
+29,169
+131% +$262K ﹤0.01% 1259
2019
Q4
$218K Sell
22,205
-12,128
-35% -$119K ﹤0.01% 1880
2019
Q3
$236K Sell
34,333
-63,284
-65% -$435K ﹤0.01% 1808
2019
Q2
$901K Sell
97,617
-52,501
-35% -$485K 0.01% 1106
2019
Q1
$2.35M Buy
150,118
+3,208
+2% +$50.3K 0.02% 641
2018
Q4
$2.27M Sell
146,910
-17,030
-10% -$263K 0.02% 602
2018
Q3
$3.53M Sell
163,940
-45,020
-22% -$970K 0.03% 507
2018
Q2
$5.08M Buy
208,960
+10,533
+5% +$256K 0.05% 375
2018
Q1
$3.39M Sell
198,427
-10,836
-5% -$185K 0.03% 475
2017
Q4
$3.97M Sell
209,263
-34,670
-14% -$657K 0.04% 423
2017
Q3
$4.29M Sell
243,933
-105,797
-30% -$1.86M 0.05% 371
2017
Q2
$11.6M Buy
349,730
+46,398
+15% +$1.54M 0.15% 168
2017
Q1
$9.73M Buy
303,332
+47,809
+19% +$1.53M 0.13% 190
2016
Q4
$9.26M Buy
255,523
+36,314
+17% +$1.32M 0.14% 183
2016
Q3
$10.1M Sell
219,209
-209,631
-49% -$9.65M 0.18% 132
2016
Q2
$21.5M Buy
428,840
+256,332
+149% +$12.9M 0.44% 58
2016
Q1
$9.23M Buy
172,508
+3,335
+2% +$178K 0.24% 100
2015
Q4
$11.1M Buy
169,173
+17,718
+12% +$1.16M 0.29% 83
2015
Q3
$8.55M Sell
151,455
-3,741
-2% -$211K 0.24% 103
2015
Q2
$9.17M Buy
155,196
+1,466
+1% +$86.6K 0.19% 120
2015
Q1
$9.58M Sell
153,730
-1,780
-1% -$111K 0.18% 136
2014
Q4
$8.94M Sell
155,510
-4,706
-3% -$271K 0.18% 126
2014
Q3
$8.61M Buy
160,216
+14,914
+10% +$802K 0.18% 127
2014
Q2
$7.62M Buy
145,302
+5,275
+4% +$277K 0.17% 134
2014
Q1
$7.4M Buy
140,027
+24,901
+22% +$1.32M 0.18% 128
2013
Q4
$4.61M Buy
115,126
+11,220
+11% +$450K 0.12% 194
2013
Q3
$3.93M Buy
103,906
+78,510
+309% +$2.97M 0.12% 205
2013
Q2
$996K Buy
+25,396
New +$996K 0.1% 230